Susquehanna International Group’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-969
| Closed | -$3.33K | – | 5965 |
|
|
2024
Q2 | $3.33K | Buy |
+969
| New | +$3.33K | ﹤0.01% | 5516 |
|
|
2023
Q3 | – | Sell |
-2,133
| Closed | -$74.5K | – | 5855 |
|
|
2023
Q2 | $74.5K | Buy |
+2,133
| New | +$74.5K | ﹤0.01% | 5108 |
|
|
2023
Q1 | – | Sell |
-56
| Closed | -$5K | – | 6265 |
|
|
2022
Q4 | $5K | Hold |
56
| – | – | ﹤0.01% | 5559 |
|
|
2022
Q3 | $3K | Hold |
56
| – | – | ﹤0.01% | 5929 |
|
|
2022
Q2 | $7K | Buy |
+56
| New | +$7K | ﹤0.01% | 5547 |
|
|
2022
Q1 | – | Sell |
-743
| Closed | -$244K | – | 6050 |
|
|
2021
Q4 | $244K | Buy |
743
+495
| +200% | +$163K | ﹤0.01% | 4743 |
|
|
2021
Q3 | $124K | Buy |
248
+116
| +88% | +$58K | ﹤0.01% | 4909 |
|
|
2021
Q2 | $72K | Buy |
132
+56
| +74% | +$30.5K | ﹤0.01% | 5112 |
|
|
2021
Q1 | $47K | Buy |
76
+18
| +31% | +$11.1K | ﹤0.01% | 5059 |
|
|
2020
Q4 | $33K | Buy |
+58
| New | +$33K | ﹤0.01% | 4653 |
|
|
2020
Q1 | – | Sell |
-71
| Closed | -$74K | – | 4744 |
|
|
2019
Q4 | $74K | Sell |
71
-13
| -15% | -$13.5K | ﹤0.01% | 3719 |
|
|
2019
Q3 | $72K | Sell |
84
-7
| -8% | -$6K | ﹤0.01% | 4147 |
|
|
2019
Q2 | $121K | Buy |
91
+24
| +36% | +$31.9K | ﹤0.01% | 4100 |
|
|
2019
Q1 | $99K | Buy |
67
+3
| +5% | +$4.43K | ﹤0.01% | 2678 |
|
|
2018
Q4 | $79K | Buy |
+64
| New | +$79K | ﹤0.01% | 3245 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 3856 |
|
|
2017
Q1 | – | Sell |
-105
| Closed | -$66K | – | 3698 |
|
|
2016
Q4 | $66K | Buy |
+105
| New | +$66K | ﹤0.01% | 3946 |
|